Heart Valve Repair and Replacement Market Global Industry Scenario, Size, Share, Trends, Analysis and Forecast, 2019 - 2028

Overview

The Heart Valve Repair & Replacement Market would foresee tremendous growth opportunities during the forecast period, i.e., 2021 – 2028, primarily due to increasing heart-related diseases. Valves are flaps that prevent the backward flow of blood in a human body. These are located in the lower chambers of the heart. In most cases, due to improper lifestyle, there occurs a scenario when one or more valves become leaky in the backward direction which is to the opposite of the blood flow’s right direction. As a result, less blood is pumped in the right direction. The heart Valve Repair & Replacement market is growing because of the increasing number of such complexities and various heart diseases. COVID-19 pandemic has forced to stay people indoors as a result of which people are lacking physical exercise and as a result, people have tended to attain fatigue and be prone to the risk of underlying heart diseases. 

Market Dynamics 

The major drivers of the heart valve repair and replacement market are various chronic heart diseases, genetic factors, obesity, and aging which is fuelling the market of the heart valve. One of the major challenges involved with the treatment and surgery is that it is not cost-efficient and installation of machinery is expensive. Moreover, a high intake of saturated trans-fat food has led to several heart diseases that as a result have boosted the demand for heart valve repair and replacement globally in the market. Also, in some critical cases, the insertion of the catheter inside a heart might cause an allergic reaction leading to infection, bleeding, blood clots which might further trigger an attack, stroke, or an even bigger problem. The lack of skilled professionals in some areas of the market and certain device-related issues is a hindrance to market growth. Recent strict regulations imposed by the government to restrict the approval for implementation of replacement are a major challenge.

Scope and Segmentation Heart Valve Repair & Replacement Market

The report is extensive research on the growth in the heart valve repair market as people want to adapt to a healthy lifestyle with an increase in age and with more advancement in lifestyle globally. The analysis of the heart valve repair & replacement market has been done through extensive research on market dynamics, its restraints or challenges, and opportunities. The market is expected to grow in the near future; a detailed study on the heart valve repair and replacement market.

has been presented in this report. It includes accurate data representation of market growth, profit and the key players of this market. The market is segmented by technology, by disease type, by application and by region. By technology, heart valve repair & replacement market can be further divided into heart valve repair and heart valve replacement. By disease type market can be further bifurcated into mitral stenosis, mitral regurgitation, aortic stenosis and aortic regurgitation. By application market can be further divided into hospitals, cardiac centers and laboratories and ambulatory surgical centers.

Key Players of Market

The prominent players of Heart Valve Repair & Replacement Market are   Abbott Laboratories, Medtronic,  St. Jude Medical, and Sorin Group, Accellent Inc., Admedes Schuessler GmbH, AorTech International, Arbor Surgical Technologies, Inc., AutoTissue GmbH, Boston Scientific, CryoLife, Inc., Colibri Heart Valve, LLC, Micro Interventional Devices, Inc., Neovasc, Inc., JenaValve Technology, Leman Cardiovascular Sa, MiCardia Corporation, On-X Life Technologies, Inc., Edwards Lifesciences Corporation, Boston Scientific Corporation, CryoLife, Inc., LivaNova PLC, Colibri Heart Valve, Micro Interventional Devices, Inc. and Braile Biomedica.

Market Segmentation of Global Heart Valve Repair and Replacement Market

By Technology

  • Heart Valve Repair
  • Heart Valve Replacement

By Disease Type

  • Mitral Stenosis
  • Mitral Regurgitation
  • Aortic Stenosis
  • Aortic Regurgitation

By Application

  • Hospitals
  • Cardiac centres and  laboratories
  • Ambulatory surgical centres

 

By Region:

  • North America
    • o    The U.S.
    • o    Mexico
    • o    Canada
    • Europe
      • o    The U.K.
      • o    Germany
      • o    France
      • o    Italy
      • o    Spain
      • o    Belgium
      • o    Switzerland
      • o    Netherlands
      • o    Rest of Europe
      • Asia Pacific
        • o    China
        • o    Japan
        • o    India
        • o    South Korea
        • o    Taiwan
        • o    Singapore
        • o    Australia
        • Rest of the World (RoW)
          • o    Central & South America
          • o    Middle East
          • o    Africa

 

FAQ (Frequently Asked Questions)

  1. What will the market value in year 2027?
  2. Who are the prominent players of the market?
  3. Which region is dominant in this market?
  4. What are the technologies used to cure the disease?

 

Back to top

Payment Options

Single User : $3,995
Five User: $5,175
Enterprise : $9,175
Datapack : $1,299
Short Report : $1,799